Virtual populations.
Real decisions.

Specialists in modelling non-communicable diseases

Tackling population health challenges means asking big questions, such as:

What impact will the increasing burden of chronic kidney disease have on healthcare costs over the next 20 years?
How can you look 10 to 20 years ahead to understand the impact of a new drug on its users and your revenue stream?
How do you determine whether it is clinically and financially feasible to progress a drug from Phase II to Phase III clinical trials?
What would be the health and economic benefits of earlier screening for the diagnosis and treatment of conditions such as chronic kidney disease or liver disease?
How can you boost a nation’s health with targeted help at different life stages?

And how do you even know which are the right questions to ask?

That’s where we can help.

Helping you make the best decisions

Our simulation and analysis expertise turns tomorrow’s population health questions and challenges into today’s focussed, specific, actionable decisions.

We can help you understand and explore those questions and challenges far into the future. Our scenario modelling will show you how different kinds of health interventions, drug innovations and policy changes can impact them.

And that will help you choose the best way forward.

Why Us?

Deep expertise in modelling non-communicable diseases, combined with entrepreneurial vision.

Why Us?

How do we do it?

We’ve created a specific process to help you find, ask and answer the right questions.

Method

What have we done?

We’ve answered many different kinds of questions for many different organisations in over 70 countries.

Track Record

Why choose us?

We have an experienced and multi-disciplinary team of software engineers, population health and policy research experts, and mathematicians.

Team

HealthLumen Blog

Estimating the prevalence and future burden of rare genetic diseases: challenges and solutions

Please Take the Survey Genetic diseases are conditions caused by abnormalities in an individual’s DNA. They can be inherited from one or both parents, or can occur as a result of spontaneous genetic mutations. They may be caused by a mutation in a single gene (monogenic); by a chromosomal change where there are more or […]

Read

Early intervention for preventing NCDs: generating evidence for the health and economic impact, using microsimulation modelling

Non-communicable diseases (NCDs), including heart disease, stroke, cancer, diabetes and chronic lung disease, are the leading causes of death worldwide.  A recent report by FP Analytics sets out the scale of the problem and the health and economic burden of NCDs.  These conditions share a common set of risk factors of which the main ones […]

Read

NEWS: HealthLumen to participate in air pollution project funded by UK Research and Innovation (UKRI)

HealthLumen is part of a consortium that has been a awarded a £50,000 Fast Start: Innovation grant to undertake a pilot project in Sandwell to reduce poor air quality through community measures. Air pollution is a major environmental cause of early death: it is also responsible for short- and long-term respiratory conditions such as asthma and lung […]

Read

Impactability Modelling for Population Health Management

We’re looking forward to attending the NHS Population Health conference on 2nd November which will bring together NHS professionals to discuss PHM strategies aimed at addressing the many pressing issues facing the NHS. Our COO and co-founder Laura Webber, will be giving a talk on Population Health Management of non-communicable diseases: measuring the impact of […]

Read